Prognostic factors and treatment modalities in uterine sarcoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 25, Issue 3, 2002, Pages 256-260

  El Husseiny, Gamal ^a   Al Bareedy, N ^a   Mourad, W A ^a   Mohamed, G ^a   Shoukri, M ^a   Subhi, J ^a   Ezzat, A ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HORMONE;

ABDOMINAL HYSTERECTOMY; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOSARCOMA; FEMALE; HORMONAL THERAPY; HUMAN; LEIOMYOSARCOMA; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; METASTASIS; MULTIVARIATE ANALYSIS; PELVIS LYMPH NODE; POSTMENOPAUSE; PREMENOPAUSE; PROGNOSIS; SALPINGOOOPHORECTOMY; SURVIVAL RATE; TREATMENT OUTCOME; UTERUS SARCOMA;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVARIECTOMY; PROGNOSIS; RADIOTHERAPY DOSAGE; SARCOMA; SURVIVAL ANALYSIS; UTERINE NEOPLASMS;

EID: 0036275433     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200206000-00010     Document Type: Article

References (19)

1. Uterine sarcomas: The Curie Institute experience. Prognosis factors and adjuvant treatments
2. Survival, patterns of spread and prognostic factors in uterine sarcoma: A study of 76 patients
3. Uterine sarcomas: Prognostic factors and treatment modalities-study of 209 patients
4. Uterine sarcomas: A review of the Edinburgh experience from 1974 to 1992
5. Uterine sarcomas in Norway 1956-1992: Incidence, survival and mortality
6. Uterine cancer - The KK Hospital experience
7. Retrospective analysis of 318 cases of uterine sarcoma
8. Uterine sarcoma: A clinicopathological study of 93 cases
9. Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumors when adjusting for known prognostic factors: The result of a retrospective study of 423 cases of uterine sarcoma
10. Prognostic features of sarcomas and mixed tumor of the endometrium
11. Uterine sarcoma managed by surgery followed by radiation therapy. Clinical outcome, prognostic factors and role of radiation therapy
12. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group Study
13. The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial sarcoma
14. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas
15. Radiotherapy in the treatment of sarcoma of the corpus uteri
16. Adjuvant therapy for stage I uterine sarcoma
17. Impact of radiotherapy on local control and survival in uterine sarcomas: A retrospective study from the Group Oncologic Catala-Occita
18. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: A Gynecologic Oncology Group study